All posts

NVEI stock (TSX:NVEI) has target slashed by National Bank

Shares of Canadian fintech company Nuvei (Nuvei Stock Quote, Charts, News, Analysts, Financials NASDAQ:NVEI) fell hard after its latest earnings release. But fans of the stock should keep their eyes on the solid growth numbers in its core business, says analyst Richard Tse of National Bank Financial.

Tse looked over the quarter in a Wednesday report to clients where he maintained an “Outperform” rating on NVEI while lowering his target price from $50.00 to $27.00.

Nuvei, which has a payments platform for mobile commerce and e-commerce markets, reported its second quarter 2023 financials on Wednesday, with revenue rising 45 per cent year-over-year to $307.0 million and adjusted EBITDA improving by 19 per cent to $110.3 million.

“The quarter was notable for the number of new customer wins and growing pipeline across all regions, as well as wallet share expansion opportunities with existing customers, underscoring momentum in the business and laying the foundation for sustainable long-term growth,” said Philip Fayer, Nuvei Chair and CEO, in a press release. 

Nuvei stock fell a full 39 per cent in trading on Wednesday, with Tse saying underwhelming third quarter and full-year 2023 guidance. Tse called the Q2 numbers mixed, with the $307.0 million topline comparing to his estimate at $308.5 million and the consensus expectation at $305.9 million, while Adjusted EBITDA at $110.3 million was above Tse’s estimate at $108.8 million and the Street’s call at $107.4 million.

As for its guidance, Nuvei is forecasting Q3 2023 revenue at $300-$308 million and adjusted EBITDA at $105-$110 million, whereas Tse’s prior estimates were $316 million in revenue and $121 million in EBITDA and the consensus estimates were $314 million in revenue and $122 million in EBITDA.

For the full 2023 year, guidance was at $1,170-$1,195 million in revenue and $417-$432 million in Adjusted EBITDA compared to Tse’s projection of $1,244 million in revenue and $466 million in EBITDA and the Street’s estimates at $1,242 million in revenue and $468 million in EBITDA.

Despite the dimmer picture from management, Tse still liked what he saw from operations, where Global eCommerce sales showed solid growth of 34 per cent year-over-year in organic constant currency and its Emerging B2B, government and integrated payments channel segment showing revenue growth of 13 per cent.

“The strong growth rate in those core business segments combined with the Company’s re-rated valuation today (7.8x F24E EV/EBITDA versus a peer average of 14.1x) is why we’re maintaining our Outperform despite some obvious challenges but with a revised target of $27 (was $50) to reflect our revised DCF assumptions,” Tse wrote.

At the time of publication, Tse’s new $27 target represented a projected one-year return of 46.5 per cent.

Tagged with: nvei
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Trade uncertainty is here to stay, RBC says

What's the latest on Donald Trump's tariffs? You might want to check your watch, not your calendar say economists at… [Read More]

17 hours ago

Rubicon Organics is still a buy, Haywood says

Its fourth quarter results are in the books and Haywood analyst Neal Gilmer has maintained his "Buy" rating on Rubicon… [Read More]

18 hours ago

Will BlackBerry survive tariffs?

Following the company's fourth quarter results, RBC analyst Paul Treiber has cut his price target on BlackBerry (BlackBerry Stock Quote,… [Read More]

18 hours ago

Exro Technologies downgraded at National Bank

Following the company's fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies (Exro Technologies Stock Quote,… [Read More]

1 day ago

Organigram acquisition gets thumbs up at Haywood

Following the company's most recent acquisition, Haywood analyst Neal Gilmer has maintained his "Buy" rating on Organigram (Organigram Stock Quote,… [Read More]

2 days ago

RBC maintains “Hold” rating on BlackBerry

RBC analyst Paul Treiber is still not fully convinced that BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB) is… [Read More]

2 days ago